All Articles

As Black Friday looms, a new partnership between GOFO and Peoples Post highlights a massive shift in how e-commerce survives the Q4 logistics crunch.

As Belgium modernizes its national rail network, a mid-cap Nordic tech firm is quietly dominating the European passenger information systems market.

As superweeds threaten global food security, a new East-West partnership aims to equip Asian rice farmers with the tools they need to survive and thrive.

HIT is deploying AI and metaverse courses in rural classrooms. Beyond charity, it is a strategic talent pipeline fueling China’s long-term space ambitions.

The NMPA approval of a 6-month prostate cancer drug reveals how mid-tier biotechs navigate China's complex healthcare landscape via strategic partnerships.

Ahead of SPS 2026, Phoenix Contact is shifting industrial automation by decoupling control logic from hardware and racing to meet CRA cybersecurity mandates.

As US-China tech decoupling accelerates, Asian venture capital is finding a new home in Europe. Helen Davis explores the shifting global venture map.

As startups race to integrate AI into wealth management, the true test lies in regulatory reality, operational safeguards, and algorithm transparency.

A new card-linked platform in Seattle and Edmonton shifts the burden of charitable giving from consumers to merchants, transforming local community support.

Four Corners Property Trust expands its portfolio with a $2.3M auto service sale-leaseback, highlighting a strategic shift toward recession-proof retail.

For institutional investors, aging urban plumbing presents a hidden ESG liability. Why precise point-of-use water data is the new mandate for CRE portfolios.

CrowdStrike’s latest battle with an offshore LLC highlights the hidden dangers of mini-tender offers and the regulatory gaps threatening retail investors.

A recent Nasdaq deficiency notice for Singapore's CytoMed Therapeutics highlights the intense market pressures facing pre-revenue biotechs today.

As Artisan Partners reports a dip to $168.7B in Q3 assets, the underlying numbers reveal a profound institutional pivot toward alternative credit and de-risking.

By swapping cheap short-term debt for expensive long-term notes, the education giant secures the runway needed to fund its aggressive digital transformation.

NurExone Biologic reports statistically significant preclinical data for its exosome therapy, taking a crucial step toward reversing optic nerve damage.

East Side Games Group has swapped legacy debt for government-backed export financing. Helen Davis explores how the mobile studio engineered a lifeline.

Rosenwald Private Wealth’s $1.1 billion move to Indivisible Partners highlights a massive strategic shift in wealth management toward tech-enabled independence.

GenZone surpasses 2,300 global entity formations as international founders increasingly leverage unified platforms to navigate dual-jurisdiction complexities.

BAB Inc. reported an 18% revenue spike, but the real story behind its Q3 success lies in pass-through accounting and a masterclass in corporate cost-cutting.